| Audit of molecular mechanisms of primary and secondary resistance to various generations of tyrosine kinase inhibitors in known epidermal growth factor receptor-mutant non … M Suryavanshi, J Jaipuria, S Mattoo, S Dhandha, M Khatri Clinical Oncology 34 (11), e451-e462, 2022 | 9 | 2022 |
| Robust home brew fragment sizing assay for detection of MET exon 14 skipping mutation in non–small cell lung cancer patients in resource constrained community hospitals A Mehta, S Nathany, A Chopra, S Mattoo, D Kumar, MK Panigrahi Journal of Pathology and Translational Medicine 55 (5), 324, 2021 | 1 | 2021 |
| Malfeasance of KRAS mutations in carcinogenesis R Tripathi, S Nathany, A Mehta, U Batra, S Mattoo, M Sharma Clinical and Experimental Medicine 21, 439-445, 2021 | 1 | 2021 |
| Clinicopathological aspects of V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) mutated non-small cell lung carcinoma in an Indian cohort: is there a difference? U Batra, S Nathany, M Sharma, S Mattoo, A Mehta, JT Jose International Journal of Molecular Epidemiology and Genetics 12 (6), 112, 2021 | 1 | 2021 |
| MET exon 14 skipping in NSCLC: An unMET Indian need. U Batra, S Nathany, M Sharma, A Patel, A Mehta, S Mattoo, V Noronha, ... Journal of Clinical Oncology 42 (16_suppl), e13537-e13537, 2024 | | 2024 |
| Increased NGS testing and real-world clinical usage of targeted therapy: All dressed up, nowhere to go. U Batra, S Nathany, M Sharma, A Patel, S Mattoo, A Mehta Journal of Clinical Oncology 42 (16_suppl), e13758-e13758, 2024 | | 2024 |
| Spectrum of Resistance Mechanisms to ALK TKIs in NSCLC: Largest Single-Center Experience from India U Batra, S Nathany, M Sharma, BP Amrith, S Vaidya, S Mattoo, D Kumar, ... South Asian Journal of Cancer, 2024 | | 2024 |
| L858R-K860I Doublet Mutation of EGFR gene in Non-Small Cell Lung Carcinoma: Cause of a False Negative Call for L858R on Initial Companion Diagnostic Test A Mehta, H Diwan, S Nathany, S Mattoo, D Kumar, MK Panigrahi Journal of Current Oncology 6 (1), 32-34, 2023 | | 2023 |
| KRAS mutated Non‐Small Lung Carcinoma: A Real World Context from the Indian subcontinent U Batra, S Nathany, M Sharma, A Bp, JT Jose, H Singh, S Mattoo, ... Cancer Medicine 12 (3), 2869-2874, 2023 | | 2023 |
| Novel germline SMARCA4 mutation in Small Cell Carcinoma of the Ovary, Hypercalcemic Type A Mehta, H Diwan, D Karki, D Bansal, M Kamboj, A Sharma, S Nathany, ... Current Problems in Cancer: Case Reports 8, 100205, 2022 | | 2022 |
| 395P Molecular landscape of Indian NSCLC: Is NGS the answer? U Batra, S Nathany, M Sharma, A Bansal, P AB, S Pasricha, A Mehta, ... Annals of Oncology 33, S1596, 2022 | | 2022 |
| 269P MET alterations in EGFR mutated NSCLC: A lesser known evil M Sharma, U Batra, S Nathany, S Mattoo, S Pasricha Annals of Oncology 33, S1538, 2022 | | 2022 |
| Unusual Resistance Mechanisms in a Case of ROS1-Rearranged NSCLC: A Case Report U Batra, S Nathany, M Sharma, S Mattoo, JT Jose, A Mehta JTO Clinical and Research Reports 3 (3), 100286, 2022 | | 2022 |
| A peek into the world of CLL genomics A Mehta, H Diwan, S Mattoo Journal of Current Oncology 5 (1), 46, 2022 | | 2022 |
| Somatic hypermutation in CLL: From bench to bedside S Nathany, A Mehta, H Diwan, D Kumar, S Mattoo, S Dhanda, ... Journal of Current Oncology 5 (1), 52-52, 2022 | | 2022 |
| P45. 02 Molecular Profile of Resistance Mutations Post Multiple Lines of Tyrosine Kinase Inhibitors in ALK-Positive Non-Small-Cell Lung Cancer M Suryavanshi, S Mattoo, S Dhandha, U Batra, A Mehta Journal of Thoracic Oncology 16 (10), S1084-S1085, 2021 | | 2021 |
| P48. 03 Spectrum of Resistance Mechanisms to First, Second and Third Generation Tyrosine Kinase Inhibitors in EGFR Mutant NSCLC Patients M Suryavanshi, S Mattoo, S Dhandha, A Mehta, U Batra Journal of Thoracic Oncology 16 (10), S1106-S1107, 2021 | | 2021 |
| Primary and secondary resistance mechanisms in first, second and third generation tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer patients. M Suryavanshi, S Mattoo, SK Sharma, A Mehta, U Batra Journal of Clinical Oncology 39 (15_suppl), e21142-e21142, 2021 | | 2021 |
| 5P False positive errors in RNA based next generation sequencing of exon 14 skipping mutations in NSCLC M Suryavanshi, S Mattoo, U Batra, S Sharma, D Kumar, A Mehta Journal of Thoracic Oncology 16 (4), S701, 2021 | | 2021 |
Moushumi SuryavanshiHead & Senior Consultant Amrita Institute of Medical Sciences and Research Center, DelhiVerified email at fbd.amrita.edu
